Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

Share the Post

Related Posts

Know the interactions between HIV and Hep C medicines
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets